Estrogen receptor beta-mediated proliferative inhibition and apoptosis in human breast cancer by calycosin and formononetin

Cellular Physiology and Biochemistry

Volumn 32, Issue 6, 2013, Pages 1790-1797

  Chen, Jian ^a   Zhao, Xinge ^a   Ye, Yu ^b   Wang, Yong ^a   Tian, Jing ^a  

^a GUILIN MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Calycosin; Estrogen receptor ; Formononetin; Insulin like growth factor 1 receptor; miR 375

Indexed keywords

CALYCOSIN; ESTROGEN RECEPTOR BETA; FORMONONETIN; ISOFLAVONE DERIVATIVE; MICRORNA 375; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MESSENGER RNA;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; BREAST CANCER CELL LINE; CELL GROWTH; FLOW CYTOMETRY; GENE EXPRESSION; GENE INACTIVATION; IN VITRO STUDY; MCF 7 CELL LINE; MTT ASSAY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; ISOFLAVONES; MCF-7 CELLS; MICRORNAS; POLY(ADP-RIBOSE) POLYMERASES; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; UP-REGULATION;

EID: 84890475064     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000356612     Document Type: Article

References (24)

1. Bray F, Jemal A, Grey N, Ferlay J, Forman D: Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012;13:790-801.
2. Królik M, Milnerowicz H: The effect of using estrogens in the light of scientific research. Adv Clin Exp Med 2012;21:535-543.
3. Liang J, Shang Y: Estrogen and cancer. Annu Rev Physiol 2013;75:225-240.
4. Chen KI, Erh MH, Su NW, Liu WH, Chou CC, Cheng KC: Soyfoods and soybean products: from traditional use to modern applications. Appl Microbiol Biotechnol 2012;96:9-22
5. Mense SM, Hei TK, Ganju RK, Bhat HK: Phytoestrogens and breast cancer prevention: possible mechanisms of action. Environ Health Perspect 2008;116:426-433.
6. Lin AH, Li RW, Ho EY, Leung GP, Leung SW, Vanhoutte PM, Man RY: Differential ligand binding affinities of human estrogen receptor-α isoforms. PLoS One 2013;8:e63199.
7. Tian J, Duan YX, Bei CY, Chen J: Calycosin induces apoptosis by upregulation of RASD1 in human breast cancer cells MCF-7. Horm Metab Res 2013;45:593-598.
8. Chen J, Sun L: Formononetin-induced apoptosis by activation of Ras/p38 mitogen-activated protein kinase in estrogen receptor-positive human breast cancer cells. Horm Metab Res 2012;44:943-948.
9. Pollak M: The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer 2012;12:159-169.
10. Zhao Y, Wang Z, Jiang Y, Yang C: Inactivation of Rac1 reduces Trastuzumab resistance in PTEN deficient and insulin-like growth factor I receptor overexpressing human breast cancer SKBR3 cells. Cancer Lett 2011;313:54-63.
11. Chen J, Zeng J, Xin M, Huang W, Chen X: Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo. Horm Metab Res 2011;43:681-686.
12. Kang NH, Hwang KA, Lee HR, Choi DW, Choi KC: Resveratrol regulates the cell viability promoted by 17β-estradiol or bisphenol A via down-regulation of the cross-talk between estrogen receptor α and insulin growth factor-1 receptor in BG-1 ovarian cancer cells. Food Chem Toxicol 2013;59:373-379.
13. Grober OM, Mutarelli M, Giurato G, Ravo M, Cicatiello L, De Filippo MR, Ferraro L, Nassa G, Papa MF, Paris O, Tarallo R, Luo S, Schroth GP, Benes V, Weisz A: Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation. BMC Genomics 2011;12:36.
14. Renoir JM, Marsaud V, Lazennec G: Estrogen receptor signaling as a target for novel breast cancer therapeutics. Biochem Pharmacol 2013;85:449-465.
15. Worralti C, Nedelcu D, Serly J, Suleymanova N, Oprea I, Girnita A, Girnita L: Novel mechanisms of regulation of IGF-1R action: functional and therapeutic implications. Pediatr Endocrinol Rev 2013;10:473-484.
16. Xue M, Cao X, Zhong Y, Kuang D, Liu X, Zhao Z, Li H: Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors in cancer therapy: advances and perspectives. Curr Pharm Des 2012;18:2901-2913.
17. Sabbatini P, Rowand JL, Groy A, Korenchuk S, Liu Q, Atkins C, Dumble M, Yang J, Anderson K, Wilson BJ, Emmitte KA, Rabindran SK, Kumar R: Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinase. Clin Cancer Res 2009;15:3058-3067.
18. Ma CX, Suman VJ, Goetz M, Haluska P, Moynihan T, Nanda R, Olopade O, Pluard T, Guo Z, Chen HX, Erlichman C, Ellis MJ, Fleming GF: A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat 2013;139:145-153.
19. Tang H, Liao Y, Chen G, Xu L, Zhang C, Ju S, Zhou S: Estrogen upregulates the IGF-1 signaling pathway in lung cancer through estrogen receptor-β. Med Oncol 2012;29:2640-2648.
20. Gupta S, Kass GE, Szegezdi E, Joseph B: The mitochondrial death pathway: a promising therapeutic target in diseases. J Cell Mol Med 2009;13:1004-1033.
21. Sukhanova MV, Khodyreva SN, Lavrik OI: Influence of poly(ADP-ribose) polymerase-1 and its apoptotic 24- kD fragment on repair of DNA duplexes in bovine testis nuclear extract. Biochemistry (Mosc) 2006;71:736-748.
22. Harquail J, Benzina S, Robichaud GA: MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis. Cancer Biomark 2012;11:269-280.
23. Rivas MA, Venturutti L, Huang YW, Schillaci R, Huang TH, Elizalde PV: Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. Breast Cancer Res 2012;14:R77.
24. de Souza Rocha Simonini P, Breiling A, Gupta N, Malekpour M, Youns M, Omranipour R, Malekpour F, Volinia S, Croce CM, Najmabadi H, Diederichs S, Sahin O, Mayer D, Lyko F, Hoheisel JD, Riazalhosseini Y: Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor α in breast cancer cells. Cancer Re 2010;70:9175-9184.